Question 1

What is Andrew A. Pieper?

Accepted Answer

Andrew A. Pieper is a Person.

Question 2

How often does Andrew A. Pieper appear in global news?

Accepted Answer

Tracked across 2 news events drawn from 13 articles.

Question 3

When was Andrew A. Pieper first tracked by Ergen?

Accepted Answer

First tracked on Dec 23, 2025.

Question 4

When was Andrew A. Pieper last mentioned in news?

Accepted Answer

Last active on Jul 09, 2026.

Question 5

What is Andrew A. Pieper's current news sentiment?

Accepted Answer

Aggregate sentiment score: 55 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Andrew A. Pieper in global news coverage?

Accepted Answer

Attention score of 6, derived from article volume and coverage intensity across 2 events.

Question 7

What is the most recent event involving Andrew A. Pieper?

Accepted Answer

Alzheimer's Reversal in Mouse Models (Dec 23, 2025, 7 articles).

Question 8

How did the "Alzheimer's Reversal in Mouse Models" event impact Andrew A. Pieper?

Accepted Answer

Andrew A. Pieper, MD, PhD, is the senior author of the study and co-founder of Glengarry Brain Health, playing a crucial role in both the scientific discovery and the commercialization of the P7C3-A20 compound.

Question 9

How did the "15-PGDH inhibition protects in Parkinson's models" event impact Andrew A. Pieper?

Accepted Answer

Co-lead researcher; recognition may lead to further funding and collaborations.

Question 10

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.